Navigation Links
Boston Scientific Begins PLATINUM PLUS Trial for PROMUS(R) Element(TM) Stent System
Date:5/25/2010

Madrid, Spain. Results are expected to be presented in 2012.

"We are very enthusiastic about beginning the first large-scale randomized trial that compares the new platinum chromium PROMUS Element Stent with the XIENCE PRIME Stent," said Dr. Fajadet. "The results should demonstrate how two distinct stent platforms, with the same everolimus drug, perform in a head-to-head comparison."

The PROMUS Element Stent is designed specifically for coronary stenting. The novel stent architecture and proprietary platinum chromium alloy combine to offer greater radial strength and flexibility. The stent architecture helps create consistent lesion coverage and drug distribution while improving deliverability, which is enhanced by an advanced catheter delivery system. The higher density alloy provides superior visibility and reduced recoil while permitting thinner struts compared to prior-generation stents[1].

The PLATINUM PLUS trial is coordinated by the Centre Europeen de Recherche Cardiovasculaire (CERC) under the direction of Marie-Claude Morice, M.D. CERC is an interventional cardiology clinical research organization based in Paris.

"This is an important study that could provide insights on the potential benefits of third-generation drug-eluting stents in an all-comers trial reflecting the daily clinical practice of interventional cardiologists," said Dr. Morice.

The PLATINUM PLUS trial will provide data that may complement Boston Scientific's PLATINUM clinical trial, which completed enrollment of 1,531 patients at 133 sites worldwide in September 2009. PLATINUM is a randomized, controlled, pivotal trial designed to support U.S. Food and Drug Administration (FDA) an
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Boston Scientific to Explore Sale of Cardiac Surgery and Vascular Surgery Businesses
2. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
3. Boston Scientific Amends Credit Facility and Prepays $1 Billion on Loan
4. Boston Scientific to Participate in the Bear Stearns 20th Annual Healthcare Conference
5. Revolutionary Genomics Research Group Opens Boston Office; Provides DNA Evidence in Workers Comp Cases
6. Boston Scientific Announces Election of Ray Elliott to Its Board of Directors
7. Alliance for Medical Devices, Instrumentation and Diagnostics formed between Fraunhofer Center for Manufacturing Innovation and Boston University
8. Boston Scientific Releases Remote Monitoring Data from its Wireless LATITUDE(R) Patient Management System
9. Genzyme Begins Major Expansion of Boston Manufacturing Facility
10. New Scientists Boost Disease-based Research at Boston Biomedical Research Institute
11. Boston Scientific to Webcast Conference Call Discussing Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2014)... August 19, 2014 2014 Deep ... is a professional and in-depth research report on ... Linalool information, including its definition, classification, application, ... overview. This research covers the international market analysis, ... industry analysis covering macroeconomic environment & economic situation ...
(Date:8/18/2014)... , Aug. 18, 2014 /PRNewswire/ - SQI Diagnostics Inc. ... commercializes proprietary technologies and products for advanced microarray diagnostics, ... on Friday, August 22 at 2:00 pm ET.  ... CEO, will provide a brief review of SQI,s recent ... , a diagnostics industry veteran recently appointed to the ...
(Date:8/18/2014)... , Aug. 18, 2014   Sterne, Kessler, ... firm in Washington, DC , announced ... Inter Partes Review (IPR) with the U.S. Patent ... a subsidiary of BioReference Laboratories, Inc. (Nasdaq: BRLI).  These ... or licensed by Myriad Genetics, Inc. These patents have ...
(Date:8/18/2014)... HIV Infection Drug Market and Pipeline Insight is a ... infection and the number of deaths due to AIDS has ... the globe. It has been estimated that the death rate ... with the rates for children being even much lower. A ... has been the improved access to antiretroviral drugs and therapy ...
Breaking Biology Technology:Linalool Industry & Diphenylamine Market (Global, China) 2014 Analysis Now Available at DeepResearchReports.com 2Linalool Industry & Diphenylamine Market (Global, China) 2014 Analysis Now Available at DeepResearchReports.com 3Linalool Industry & Diphenylamine Market (Global, China) 2014 Analysis Now Available at DeepResearchReports.com 4SQI Diagnostics Announces Investor Conference Call with Dr. Allan Pronovost 2SQI Diagnostics Announces Investor Conference Call with Dr. Allan Pronovost 3Sterne Kessler Files 11 IPR Petitions On Behalf Of GeneDx, Inc., Subsidiary Of BioReference Laboratories, Inc. 2Sterne Kessler Files 11 IPR Petitions On Behalf Of GeneDx, Inc., Subsidiary Of BioReference Laboratories, Inc. 3Global HIV Infection Drug Market Overview 2Global HIV Infection Drug Market Overview 3Global HIV Infection Drug Market Overview 4
... ConBio Lasers to be Exclusively Featured in Leading Dental Education ... ... 12 HOYA ConBio(TM), a global,leader in dental and aesthetic ... internationally recognized dental education,company, in which VersaWave(TM) and DioDent(TM) Micro ...
... Mersana, a cancer,therapeutics company, announced today that Timothy ... Officer., "We are thrilled that Tim is now ... President and CEO at Mersana. "His extensive leadership in,oncology ... an,ideal match for Mersana. In addition to the important ...
... CuraGen Corporation,(Nasdaq: CRGN ) announced today that ... present at the BIO CEO & Investor Conference,on Wednesday, ... Access to a live webcast of the presentation ... the webcast will be accessible,beginning one hour after the ...
Cached Biology Technology:HOYA ConBio and The Hornbrook Group Announce Expanded Alliance 2HOYA ConBio and The Hornbrook Group Announce Expanded Alliance 3Mersana Therapeutics, Inc. Appoints Chief Scientific Officer, Timothy B. Lowinger, Ph.D. 2
(Date:8/20/2014)... melanomas the rare type of skin cancer that caused ... other more common types of skin cancer, according to a ... Cell & Melanoma Research . , Acral melanoma most often ... nail-beds and other hairless parts of the skin. Unlike other ... damage from the sun. , The team, from the Cancer ...
(Date:8/20/2014)... synthetic rugs and plastic bags could one day be ... than petroleum, scientists are now reporting. The novel process ... world deal with its agricultural and plastic waste problems, ... Athanassia Athanassiou, Ilker S. Bayer and colleagues at the ... is constantly growing. In 2012, its production reached 288 ...
(Date:8/20/2014)... and its energy is finally utilized for the ... mostly build from silicon based semiconductors, also harness ... the development of cheaper and renewable photovoltaics consists ... protein complexes of photosynthesis. Prof. Dr. Matthias Rgner,s ... cyanobacteria that live in a hot spring in ...
Breaking Biology News(10 mins):Scientists learn more about rare skin cancer that killed Bob Marley 2A semi-artificial leaf faster than 'natural' photosynthesis 2
... from King,s College London have identified patterns of epigenetic ... genetically identical twins who differ in autism traits. The ... largest of its kind and may shed light on ... activity of certain genes and in turn contribute to ...
... , April 22, 2013 The U.S. Farmers  & ... from multiple disciplines, including farmers, media, industry and academia,  ... This discussion was moderated by CNBC Senior Analyst and ... Chicago , which took place during ...
... WHAT: ... Charitable Trusts as the "Biomedical Researcher of the Month," for his ... As a postdoctoral researcher in the Princeton University laboratory of Lynn ... type 1 (HSV-1)which, in rare cases, can lead to blindness or ...
Cached Biology News:Epigenetic changes shed light on biological mechanism of autism 2Epigenetic changes shed light on biological mechanism of autism 3CNBC Senior Analyst Ron Insana Moderates Discussion On Biotech Seeds At The Food Dialogues(SM): Chicago 2CNBC Senior Analyst Ron Insana Moderates Discussion On Biotech Seeds At The Food Dialogues(SM): Chicago 3Viral curiosity spreads across continents 2
KNP-1 (HES1) Purified Anti-Mouse, Anti-Rat, Anti-Human, Anti-Dog, Anti-Chicken clone 35, Isotype Mouse IgG 1 , 150 µg Consult technical datasheet for details....
... E978 GenBank Accession ... Immunogen : NY-ESO-1 full-length ... ascites with 0.05% sodium ... evaluated by immunoblot on ...
NATIVE RAT OSTEOCALCIN...
Form: Ready to use Applications: Immunohistology-frozen, Immunohistology-paraffin, Western Blot, ELISA...
Biology Products: